• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Sun Pharma
Pharma

Sun Pharma snaps up women's health leader Organon for $11.75B

Sun Pharma has agreed to pay $11.75 billion for Organon in a merger of companies that each generated sales of $6.2 billion last year.
Kevin Dunleavy Apr 27, 2026 11:06am
On target clinical trial success bullseye score

Mundipharma, CorMedix score trial victory for antifungal Rezzayo

Apr 27, 2026 3:52pm
Astellas

Lessons from the eye: How cell therapy is shaping the future of regenerative medicine

Brought to you by ASTELLAS
Food and Drug Administration

Regulatory tracker: FDA clears new dosing for AZ's Saphnelo

Apr 27, 2026 3:07pm
Astellas

Astellas projects Xtandi decline but overall growth in FY2026

Apr 27, 2026 11:30am
settlement

Pfizer inks settlements with 2 generic Vyndamax contenders

Apr 27, 2026 11:23am
More News

Ligand lays out $739M for royalty aggregator compatriot Xoma

Apr 27, 2026 10:19am

The Oral GLP-1 Tracker: Lilly's launch of Foundayo lags in Week 2

Apr 24, 2026 4:10pm

UPDATED: Roche Q1 earnings see hits and misses across key products

Apr 24, 2026 1:55pm

AbbVie, Grace Therapeutics receive manufacturing-related CRLs

Apr 24, 2026 11:37am
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings